for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Celldex Therapeutics Q4 Loss Per Share $0.64

Celldex Therapeutics Inc:

* CELLDEX PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND YEAR END 2019 RESULTS

* Q4 LOSS PER SHARE $0.64

* Q4 REVENUE $900,000 VERSUS $9.5 MILLION

* CELLDEX THERAPEUTICS - BELIEVES CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AT DEC 31, 2019 SUFFICIENT TO FUND PLANNED OPERATIONS INTO Q1 2021 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up